The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG_GU experience.
Francisco Javier Afonso
No relevant relationships to disclose
Ovidio Fernández Calvo
No relevant relationships to disclose
Emilio Esteban
Consultant or Advisory Role - Pfizer
Elena Fernández Gabriel
No relevant relationships to disclose
Sergio Vazquez-Estevez
No relevant relationships to disclose
Urbano Anido
No relevant relationships to disclose
Martin Lázaro Quintela
No relevant relationships to disclose
Lucía Santomé
No relevant relationships to disclose
Manuel Ramos Vazquez
No relevant relationships to disclose
Begoña Campos Balea
No relevant relationships to disclose
Luis Leon Mateos
No relevant relationships to disclose
Jose-luis Firvida
No relevant relationships to disclose
Luis Anton Aparicio
No relevant relationships to disclose